2-amino-4-phosphonobutyric acid has been researched along with reserpine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Albin, RL; Becker, JB; Frey, KA; Kearney, JA | 1 |
Conn, PJ; DiLella, AG; Kinney, GG; Lis, E; Marino, MJ; Valenti, O; Wittmann, M | 1 |
Duty, S; MacInnes, N; Messenger, MJ | 1 |
Ansari, MS; Baldwin, RM; Bubser, M; Conn, PJ; Johnson, KA; Jones, CK; Marvanova, M; Niswender, CM; Tantawy, MN | 1 |
5 other study(ies) available for 2-amino-4-phosphonobutyric acid and reserpine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
The role of nigrostriatal dopamine in metabotropic glutamate agonist-induced rotation.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Aminobutyrates; Animals; Corpus Striatum; Deoxyglucose; Desipramine; Dominance, Cerebral; Dopamine; Excitatory Amino Acid Agonists; Gene Expression Regulation; Genes, fos; Glycine; Indans; Male; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reserpine; Resorcinols; Substantia Nigra; Superior Colliculi | 1998 |
Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse.
Topics: Adrenergic Uptake Inhibitors; Aminobutyrates; Animals; Corpus Striatum; Disease Models, Animal; Electric Stimulation; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; Globus Pallidus; In Vitro Techniques; Male; Mice; Mice, Knockout; Motor Activity; Neural Inhibition; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reserpine; Synapses; Synaptic Transmission | 2003 |
Activation of group III metabotropic glutamate receptors in selected regions of the basal ganglia alleviates akinesia in the reserpine-treated rat.
Topics: Aminobutyrates; Animals; Cerebral Ventricles; Dose-Response Relationship, Drug; Globus Pallidus; Glutamic Acid; Hypokinesia; Injections, Intraventricular; Injections, Subcutaneous; Male; Movement; Phosphoserine; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reserpine; Rotation; Substantia Nigra | 2004 |
The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease.
Topics: Aminobutyrates; Animals; Benzoates; Catalepsy; Disease Models, Animal; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Agonists; Forelimb; Glycine; Haloperidol; Injections, Intraventricular; Male; Neostriatum; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Metabotropic Glutamate; Reserpine; Time Factors | 2013 |